HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Wong Selected Research

C-Reactive Protein

10/2008Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Wong Research Topics

Disease

13Ankylosing Spondylitis
05/2011 - 07/2006
3Fatigue
05/2011 - 07/2008
3Back Pain (Backache)
10/2008 - 07/2008
2Chronic Disease (Chronic Diseases)
05/2011 - 01/2009
2Arthritis (Polyarthritis)
08/2010 - 10/2008
2Pain (Aches)
07/2008 - 08/2007
2Inflammation (Inflammations)
07/2008 - 12/2007
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2010
1Spinal Diseases (Disease, Spinal)
08/2010
1Spondylarthritis (Spinal Arthritis)
07/2008
1Sacroiliitis
07/2008
1Infections
07/2006
1Necrosis
11/2004

Drug/Important Bio-Agent (IBA)

12Adalimumab (Humira)FDA Link
01/2011 - 07/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 07/2006
1Biomarkers (Surrogate Marker)IBA
10/2008
1C-Reactive ProteinIBA
10/2008
1Tumor Necrosis Factor InhibitorsIBA
07/2008
1HLA-B27 Antigen (HLA B27 Antigen)IBA
07/2008
1Monoclonal AntibodiesIBA
07/2006
1Immunoglobulin G (IgG)IBA
07/2006
1SteroidsIBA
11/2004

Therapy/Procedure

2Therapeutics
05/2011 - 01/2009
1Spinal Fusion (Spondylosyndesis)
05/2009